A coronavirus vaccine for children as young as five has taken a step closer in Australia to being recommended and could be available early in the new year. The Therapeutic Goods Administration has given its provisional approval for Pfizer’s COVID-19 vaccine for five to 11 year olds. “In making this regulatory decision, the TGA carefully considered data from clinical trials conducted in the United States, Finland, Poland and Spain which included participants 5 to 11 years of age,” the regulatory body said in a statement. “The study demonstrated effectiveness by showing that the immune response to the vaccine in children was similar to that seen in older age groups. “Clinical trials also showed that the safety profile in children is similar to that seen in adults with the observed side effects being mild. The most frequent adverse events seen in clinical trials in children aged 5-11 years were injection site pain, fatigue, …